Investigating the PD-L1:NLRP3 signaling axis as a tumor intrinsic mechanism of adaptive resistance to anti-PD-1 antibody immunotherapy
Research Grant
Administered By
Medicine, Medical Oncology
Awarded By
National Institutes of Health
Start Date
August 1, 2020
End Date
July 31, 2025
Administered By
Medicine, Medical Oncology
Awarded By
National Institutes of Health
Start Date
August 1, 2020
End Date
July 31, 2025